share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

SEC announcement ·  Apr 3 05:08
Summary by Futu AI
In a recent transaction dated 03/31/2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], has been involved in a financial activity concerning the company's stock. Unfortunately, the specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. This leaves a gap in the information necessary for investors to fully understand the implications of the transaction on their investment decisions.
In a recent transaction dated 03/31/2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], has been involved in a financial activity concerning the company's stock. Unfortunately, the specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. This leaves a gap in the information necessary for investors to fully understand the implications of the transaction on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.